Radnor Capital Management LLC cut its holdings in Oracle Co. (NYSE:ORCL – Free Report) by 7.5% during the 4th quarter, Holdings Channel reports. The firm owned 7,128 shares of the enterprise software provider’s stock after selling 575 shares during the period. Radnor Capital Management LLC’s holdings in Oracle were worth $1,188,000 at the end of the most recent reporting period.
Several other large investors have also modified their holdings of the business. Fairway Wealth LLC acquired a new stake in Oracle during the 2nd quarter valued at $27,000. Quest Partners LLC acquired a new stake in shares of Oracle during the second quarter valued at $40,000. Reston Wealth Management LLC purchased a new stake in Oracle during the 3rd quarter worth about $44,000. Avondale Wealth Management acquired a new position in Oracle in the 3rd quarter valued at about $51,000. Finally, Friedenthal Financial purchased a new position in Oracle in the 3rd quarter valued at about $51,000. 42.44% of the stock is currently owned by institutional investors and hedge funds.
Oracle Price Performance
Shares of NYSE ORCL opened at $156.34 on Wednesday. The company has a quick ratio of 0.72, a current ratio of 0.81 and a debt-to-equity ratio of 5.65. Oracle Co. has a fifty-two week low of $105.42 and a fifty-two week high of $198.31. The business has a 50 day moving average price of $176.99 and a two-hundred day moving average price of $161.24. The firm has a market cap of $437.28 billion, a PE ratio of 38.22, a price-to-earnings-growth ratio of 3.39 and a beta of 1.06.
Oracle Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Thursday, January 9th. Stockholders of record on Thursday, January 23rd were given a dividend of $0.40 per share. The ex-dividend date of this dividend was Friday, January 10th. This represents a $1.60 annualized dividend and a dividend yield of 1.02%. Oracle’s payout ratio is 39.12%.
Analysts Set New Price Targets
A number of equities analysts have recently weighed in on the stock. JMP Securities reissued a “market outperform” rating and issued a $205.00 price objective on shares of Oracle in a research report on Tuesday, December 10th. Stifel Nicolaus boosted their price target on Oracle from $155.00 to $175.00 and gave the company a “hold” rating in a report on Tuesday, December 10th. Citigroup raised their price objective on Oracle from $157.00 to $194.00 and gave the stock a “neutral” rating in a report on Tuesday, December 10th. KeyCorp upped their target price on Oracle from $190.00 to $200.00 and gave the company an “overweight” rating in a research note on Friday, November 15th. Finally, BMO Capital Markets raised their price target on Oracle from $173.00 to $205.00 and gave the stock a “market perform” rating in a research note on Tuesday, December 10th. One analyst has rated the stock with a sell rating, eleven have assigned a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Oracle currently has a consensus rating of “Moderate Buy” and an average target price of $181.48.
View Our Latest Stock Analysis on Oracle
Oracle Company Profile
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Further Reading
- Five stocks we like better than Oracle
- Consumer Staples Stocks, Explained
- 3 Dividend Stocks at Bargain Levels to Defend Your Portfolio
- 3 Warren Buffett Stocks to Buy Now
- 3 REITs With Big Dividend Growth and Sustainable Payouts
- What is Short Interest? How to Use It
- Can Integrated Healthcare Stocks Succeed in Public Markets?
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Co. (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.